BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3891875)

  • 21. Development of MoAb HMSA-2 for melanosomes of human melanoma and its application to immunohistopathologic diagnosis of neoplastic melanocytes.
    Maeda K; Jimbow K
    Cancer; 1987 Feb; 59(3):415-23. PubMed ID: 3539311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case of nodal nevus with melanocytic cell aggregates in the lymphatic hilum: A potential diagnostic pitfall that requires differentiation from metastatic melanoma of the lymph node.
    Ogawa K; Kobayashi N; Miyagawa F; Nakai T; Fukumoto T; Mitsui Y; Arai E; Asada H
    J Dermatol; 2020 Jun; 47(6):e242-e244. PubMed ID: 32201978
    [No Abstract]   [Full Text] [Related]  

  • 23. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
    Clark WH; Hood AF; Tucker MA; Jampel RM
    Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibody PAL-M1 recognizes the transferrin receptor and is a progression marker in melanocytic lesions.
    van Muijen GN; Ruiter DJ; Hoefakker S; Johnson JP
    J Invest Dermatol; 1990 Jul; 95(1):65-9. PubMed ID: 2366002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of human monoclonal antibody (2-139-1) in cutaneous melanocytic neoplasms in fixed tissue sections.
    White WL; Tam ST; Mitchell MS; Yu MC; Kan-Mitchell J
    J Histochem Cytochem; 1991 Jun; 39(6):777-85. PubMed ID: 1709658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescence in situ hybridization (FISH) analysis of melanocytic nevi and melanomas: sensitivity, specificity, and lack of association with sentinel node status.
    Fang Y; Dusza S; Jhanwar S; Busam KJ
    Int J Surg Pathol; 2012 Oct; 20(5):434-40. PubMed ID: 22561674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
    Kopera D; Hohenleutner U; Stolz W; Landthaler M
    Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study.
    Dyduch G; Okoń K; Pescarini E
    Pol J Pathol; 2011 Sep; 62(3):139-44. PubMed ID: 22102069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoperoxidase technique modified by counterstain with azure B as a diagnostic aid in evaluating heavily pigmented melanocytic neoplasms.
    Kamino H; Tam ST
    J Cutan Pathol; 1991 Dec; 18(6):436-9. PubMed ID: 1723081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of melanocytic nevi from malignant melanomas in palms, soles, and nail beds solely by signs in the cornified layer of the epidermis.
    Kerl H; Trau H; Ackerman AB
    Am J Dermatopathol; 1984; 6 Suppl():159-60. PubMed ID: 6528914
    [No Abstract]   [Full Text] [Related]  

  • 31. PRAME immunohistochemistry is useful in the evaluation of conjunctival melanomas, nevi, and primary acquired melanosis.
    LeBlanc RE; Miller DM; Zegans ME
    J Cutan Pathol; 2021 Dec; 48(12):1442-1448. PubMed ID: 34089198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysplastic melanocytic nevi of the lower leg: sex- and site-specific histopathology.
    Coras B; Landthaler M; Stolz W; Vogt T
    Am J Dermatopathol; 2010 Aug; 32(6):599-602. PubMed ID: 20534984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity.
    McNutt NS; Urmacher C; Hakimian J; Hoss DM; Lugo J
    J Cutan Pathol; 1995 Dec; 22(6):502-17. PubMed ID: 8835170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melanocytes of a melanocytic nevus in a lymph node from a patient with a primary cutaneous melanoma associated with a small congenital nevus.
    Hruban RH; Eckert F; Baricević B
    Am J Dermatopathol; 1990 Aug; 12(4):402-7. PubMed ID: 2203272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
    Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
    Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Micro-anatomy related antigen expression in melanocytic lesions.
    Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
    J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nodal melanocytic nevus with balloon-cell change (nodal balloon-cell nevus).
    Urso C
    J Cutan Pathol; 2008 Jul; 35(7):672-6. PubMed ID: 18312441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
    Fullen DR; Zhu W; Thomas D; Su LD
    J Cutan Pathol; 2005 Nov; 32(10):680-4. PubMed ID: 16293180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cutaneous melanocytic tumors. Case 2].
    Castillo C
    Ann Pathol; 2016 Oct; 36(5):322-325. PubMed ID: 27639774
    [No Abstract]   [Full Text] [Related]  

  • 40. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas.
    Rhodes AR; Harrist TJ; Day CL; Mihm MC; Fitzpatrick TB; Sober AJ
    J Am Acad Dermatol; 1983 Oct; 9(4):563-74. PubMed ID: 6630618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.